• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)].

作者信息

Eisenring J J, Dick P, Tissot R, Yanniotis G

出版信息

Psychopharmacologia. 1973 Oct 23;33(1):95-101. doi: 10.1007/BF00428797.

DOI:10.1007/BF00428797
PMID:4769026
Abstract
摘要

相似文献

1
[Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)].
Psychopharmacologia. 1973 Oct 23;33(1):95-101. doi: 10.1007/BF00428797.
2
[Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].[在患有抑郁和帕金森综合征的患者中，与左旋多巴和地昔帕明相关的脱羧酶抑制剂作用下儿茶酚胺代谢的改变]
Encephale. 1971 May-Jun;60(3):189-209.
3
L-dopa plus decarboxylase inhibitor in depression.
Lancet. 1970 Sep 26;2(7674):660-1. doi: 10.1016/s0140-6736(70)91425-x.
4
Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.左旋多巴与MK 486（L-α-甲基多巴肼）联合应用——一种帕金森病外周脱羧酶抑制剂。
Med J Aust. 1974 Mar 23;1(12):429-32.
5
[Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].[一种脱羧酶抑制剂（Ro 4-4602）与左旋多巴联合使用对抑制性抑郁的作用]
Arzneimittelforschung. 1970 Jul;20(7):934-5.
6
[Effect of a decarboxylase inhibitor (Ro 4-4602) and L-dopa on inhibited depressions. II. Experimental psychological studies].[一种脱羧酶抑制剂（Ro 4-4602）和左旋多巴对抑制性抑郁的作用。II. 实验心理学研究]
Arzneimittelforschung. 1970 Jul;20(7):932-3.
7
[Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].使用左旋多巴联合脱羧酶抑制剂治疗帕金森病
Fortschr Neurol Psychiatr Grenzgeb. 1972 Oct;40(10):564-8.
8
[Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].[左旋多巴及其甲基化衍生物（3 - OMD和4 - OMD）联合脱羧酶抑制剂治疗帕金森综合征：临床与生化研究]
Schweiz Med Wochenschr. 1973 Oct 20;103(42):1466-74.
9
[CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].[CB 154治疗帕金森病。与左旋多巴和脱羧酶抑制剂联合使用的结果]
Acta Neurol (Napoli). 1976 Jul-Aug;31(4):479-48.
10
[Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].[帕金森综合征。左旋多巴与脱羧酶抑制剂联合治疗4年的经验。临床与生化研究]
Nouv Presse Med. 1973 Feb 3;2(5):315-6.

引用本文的文献

1
Effects of thymoleptics on behaviour associated with changes in brain dopamine. I. Potentiation of dopa-induced gnawing of mice.抗抑郁药对与脑多巴胺变化相关行为的影响。I. 增强多巴诱导的小鼠啃咬行为。
Psychopharmacologia. 1976 Feb 2;45(3):261-5. doi: 10.1007/BF00421137.
2
Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.左旋多巴与脱羧酶抑制剂：其临床药理学及在帕金森病治疗中的应用综述
Drugs. 1976;11(5):329-77. doi: 10.2165/00003495-197611050-00001.

本文引用的文献

1
Parenteral Niamid in depressions. (A preliminary report).胃肠外注射烟酰胺治疗抑郁症（初步报告）
Dis Nerv Syst. 1962 Mar;23:172-4.
2
A clinical and biochemical study of a trial of iproniazid in the treatment of depression.异烟酰异丙肼治疗抑郁症试验的临床与生化研究
J Neurol Neurosurg Psychiatry. 1959 Aug;22(3):247-51. doi: 10.1136/jnnp.22.3.247.
3
CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION.二羟基苯丙氨酸（多巴）治疗抑郁症的临床经验
J Psychiatr Res. 1963 Dec;1:289-97. doi: 10.1016/0022-3956(63)90004-9.
4
[The effects of dopa on inhibited depressions].[多巴对抑制性抑郁症的影响]
Klin Wochenschr. 1966 Jun 15;44(12):727-8. doi: 10.1007/BF01790804.
5
[Orientative clinical trials on the effects of dihydroxyphenylalanine (1-dopa) in endogenous depression].[二羟基苯丙氨酸（左旋多巴）对内源性抑郁症影响的定向临床试验]
Arzneimittelforschung. 1965 Aug;15(8):849-52.
6
Retarded depression and the dopamine metabolism.迟发性抑郁与多巴胺代谢。
Psychopharmacologia. 1971;19(2):199-203. doi: 10.1007/BF00402643.
7
[Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?].
Presse Med (1893). 1971 Jan 16;79(3):91-2.
8
[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].[左旋多巴联合脱羧酶抑制剂治疗帕金森综合征。II]
Rev Neurol (Paris). 1970 Nov;123(5):297-319.
9
[Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].[在患有抑郁和帕金森综合征的患者中，与左旋多巴和地昔帕明相关的脱羧酶抑制剂作用下儿茶酚胺代谢的改变]
Encephale. 1971 May-Jun;60(3):189-209.
10
[Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
Clin Chim Acta. 1971 Jun;33(1):111-5. doi: 10.1016/0009-8981(71)90257-9.